April 22, 2008 – Medtronic, Inc. (NYSE: MDT) and Restore Medical, Inc. (NASDAQ: REST) announced that the companies have signed a definitive agreement under which Medtronic will pay $1.60 per share in cash for each share of Restore Medical stock. The total value of the transaction, including payment of Restore Medical debt will be approximately $29 million.
The transaction, which is anticipated to close within 90 days, is expected to be accretive to Medtronic earnings in the first full fiscal year after closing. Restore Medical’s Pillar Palatal Implant System (Pillar System) is an innovative, minimally invasive, implantable medical device used to treat the soft palate component of sleep breathing disorders, including mild to moderate obstructive sleep apnea (OSA) and snoring... Medtronic' Press Release -
Blog Archive
-
▼
2008
(56)
-
▼
April
(13)
- Arena : Phase 2b Clinical Trial of APD125 for the ...
- Medtronic : Agreement to Acquire Restore Medical
- Astro-Med : Home Sleep Screener as Medicare Issues...
- Southern Home Medical Equipment : Another Record M...
- Meda : exclusive world-wide commercialization righ...
- Neurogen : $30.6 Million Financing to Advance Clin...
- BTG : Positive Results from First Study Investigat...
- Itamar Medical : Watch-PAT to be included as an a...
- SleepEx : Agreement with the Atlanta School of Sle...
- SOMAXON PHARMACEUTICALS : NEW DRUG APPLICATION FOR...
- Graymark Healthcare : Letter of Intent to Acquire ...
- Jazz Pharmaceuticals, Inc. : Development Pipeline ...
- Philips : completion of Respironics acquisition
-
▼
April
(13)
Thursday, April 24, 2008
Medtronic : Agreement to Acquire Restore Medical
Libellés :
Medtronic,
obstructive sleep apnea,
Restore Medical,
snoring